Boncresa Injection, Solution
Product Images NDC 70121-2702

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Boncresa (NDC 70121-2702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

First Figure (Boncresa Denosumab Mobz Injection 1)

First Figure (Boncresa Denosumab Mobz Injection 1)
This text appears to be describing the before and after use appearance of a medical tool or device. It mentions a plunger with a clear finger grip and a transparent safety guard. It also refers to a window and a spring for needle safety. The coloring of certain caps is also mentioned. Overall, it seems to be highlighting the features and components of a medical device before and after it has been used.*
FDA Label Image

Step 1 (Boncresa Denosumab Mobz Injection 2)

FDA Label Image

Step 2a (Boncresa Denosumab Mobz Injection 3)

FDA Label Image

Step 2b (Boncresa Denosumab Mobz Injection 4)

FDA Label Image

Step 3a (Boncresa Denosumab Mobz Injection 5)

FDA Label Image

Step 3b (Boncresa Denosumab Mobz Injection 6)

FDA Label Image

Figure 1 (Boncresa Denosumab Mobz Injection 7)

FDA Label Image

Carton (Boncresa Denosumab Mobz Injection 8)

Carton (Boncresa Denosumab Mobz Injection 8)
This is information about a prefilled syringe containing 60 mg denosumab-mobyz solution for subcutaneous use. The solution also contains acetic acid, polysorbate, sorbitol, and water. It is emphasized to store the syringe in the refrigerator between 2°C to 8°C and protect it from light. The syringe should not be frozen and needs to be discarded if not used within 14 days. Before administration, it is recommended to allow the syringe to reach room temperature. The product is manufactured by Amneal Pharmaceuticals LLC and is a product of Spain. The dosage information should be consulted from the prescribing information included.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.